Winway Health Desk
Agile Therapeutics crafts hip birth control awareness campaign aimed at millennial...
With the blasé millennial declaration “I’m So Done,” Agile Therapeutics launches a platform for women to discuss and decide which contraceptive method is best for...
Vaccine skepticism rises, with fewer Americans planning immediate COVID-19 vaccination: survey
Vaccine skepticism is rising in the U.S. as political maneuvering and a trial setback make headlines and foster doubt.
Only 27% of respondents said last...
Report: One-fourth of adults with job-based coverage are underinsured
As healthcare costs continue to grow, patients are increasingly footing the bill, according to the Commonwealth Fund’s biennial health insurance survey. Even employer-based plans,...
BioNTech, CureVac bag $745M in German funding for COVID-19 vaccine hopefuls
Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a time-consuming and costly process. In...
Creating A Place Of Sanctuary For Mental Health Patients
In 2015, Mind Springs Health’s West Springs Hospital in Grand Junction, Colo., began planning a 62,000-square-foot expansion. A visioning session early in the design...
BioNTech gets more than $444M in funding from German federal government...
One of the companies developing vaccines against Covid-19 has received an infusion of funding from the German federal government.
Mainz, Germany-based BioNTech said Tuesday that...
Amid Covid-19, a longstanding coordination-of-benefits issue pressures state Medicaid agencies
I write today urging better coordination between two of our nation’s most important healthcare systems – Medicaid and TRICARE, the Department of Defense’s...
Novavax adds antigens to COVID-19 production pact with Indian vaccines giant
Despite a lackluster history of taking vaccines to market, Maryland's Novavax is streaking through clinical trials for its promising COVID-19 shot candidate. Going commercial...
Marinus scores in Phase III genetic epilepsy drug study, wins BARDA...
A small biotech company has made a deal with the federal government to develop a drug for patients with a rare seizure disorder that...
Pfizer execs see blockbuster opportunities throughout vaccine pipeline, beyond pneumonia and...
Pfizer has made billions on its best-selling vaccine, Prevnar 13, but it's meanwhile advancing several phase 3 candidates to follow that product and bolster its presence in...
